Eleonora Amante

Dr. Eleonora Amante


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Talanta
Verified
Journal Article
Closed access
EAE. Alladio
E. Alladio
EAEleonora Amante
Eleonora Amante
CBC. Bozzolino
C. Bozzolino
FSF. Seganti
F. Seganti
ASA. Salomone
A. Salomone
BDB. Desharnais
B. Desharnais

20 July 2021 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
ÁLÁngela López-Rabuñal
Ángela López-Rabuñal
DCDaniele Di Corcia
Daniele Di Corcia
EAEleonora Amante
Eleonora Amante
MMMarta Massano
Marta Massano
ACAngelines Cruz-Landeira
Angelines Cruz-Landeira
ASAlberto Salomone
Alberto Salomone
New psychoactive substances (NPS) have been introduced into the market in recent years, with new analytes reported every year. The use of these substances in women can occur at any stage of life, even in the childbearing age. Drug use during pregnancy presents significant risks for the mother and the fetus, so it is important to have tools that allow to detect prenatal exposure to these substances of abuse. Therefore, an analytical method for the determination of 137 NPS and other drugs of abuse in meconium by UHPLC-QTOF was developed and validated for semi-quantitative purpose. Linearity range, limit of detection (LOD), precision, matrix effect, selectivity, and specificity were evaluated. For all analytes, the calibration curves were studied in the ranges between 2, 10, or 50 ng/g and 750 or 1000 ng/g, (depending on the analyte) and the LOD ranged between 0.04 and 2.4 ng/g. The method was applied to 30 meconium specimens from cases in which fentanyl had been administered as epidural anesthesia at the time of delivery or cases in which the maternal hair was positive to other drug of abuse. Four meconium samples tested positive for fentanyl (range concentration = 440–750 ng/g) and two samples tested positive to acetylfentanyl (range concentration = 190–1400 ng/g).

18 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
EAEleonora Amante
Eleonora Amante
EAEugenio Alladio
Eugenio Alladio
RRRebecca Rizzo
Rebecca Rizzo
DCDaniele Di Corcia
Daniele Di Corcia
PNPierre Negri
Pierre Negri
ASAlberto Salomone
Alberto Salomone
The misuse of fentanyl, and novel synthetic opioids (NSO) in general, has become a public health emergency, especially in the United States. The detection of NSO is often challenged by the limited diagnostic time frame allowed by urine sampling and the wide range of chemically modified analogues, continuously introduced to the recreational drug market. In this study, an untargeted metabolomics approach was developed to obtain a comprehensive “fingerprint” of any anomalous and specific metabolic pattern potentially related to fentanyl exposure. In recent years, in vitro models of drug metabolism have emerged as important tools to overcome the limited access to positive urine samples and uncertainties related to the substances actually taken, the possible combined drug intake, and the ingested dose. In this study, an in vivo experiment was designed by incubating HepG2 cell lines with either fentanyl or common drugs of abuse, creating a cohort of 96 samples. These samples, together with 81 urine samples including negative controls and positive samples obtained from recent users of either fentanyl or “traditional” drugs, were subjected to untargeted analysis using both UHPLC reverse phase and HILIC chromatography combined with QTOF mass spectrometry. Data independent acquisition was performed by SWATH in order to obtain a comprehensive profile of the urinary metabolome. After extensive processing, the resulting datasets were initially subjected to unsupervised exploration by principal component analysis (PCA), yielding clear separation of the fentanyl positive samples with respect to both controls and samples positive to other drugs. The urine datasets were then systematically investigated by supervised classification models based on soft independent modeling by class analogy (SIMCA) algorithms, with the end goal of identifying fentanyl users. A final single-class SIMCA model based on an RP dataset and five PCs yielded 96% sensitivity and 74% specificity. The distinguishable metabolic patterns produced by fentanyl in comparison to other opioids opens up new perspectives in the interpretation of the biological activity of fentanyl.

15 July 2019 in Drug Testing and Analysis
Verified
Journal Article
Closed access
PDF file
EAEleonora Amante
Eleonora Amante
SPSerena Pruner
Serena Pruner
EAEugenio Alladio
Eugenio Alladio
ASAlberto Salomone
Alberto Salomone
MVMarco Vincenti
Marco Vincenti
Rasmus BroRasmus Bro
Rasmus Bro

1 March 2021 in Minerva Urology and Nephrology
Verified
Journal Article
Closed access
SLStefano DE Luca
Stefano DE Luca
EAEleonora Amante
Eleonora Amante
CFCristian Fiori
Cristian Fiori
GAGiorgio Alleva
Giorgio Alleva
EAEugenio Alladio
Eugenio Alladio
FPFrancesco Porpiglia
Francesco Porpiglia

16 August 2020 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
EAEugenio Alladio
Eugenio Alladio
EAEleonora Amante
Eleonora Amante
CBCristina Bozzolino
Cristina Bozzolino
SVSara Vaglio
Sara Vaglio
GGGiusy Guzzetti
Giusy Guzzetti
MVMarco Vincenti
Marco Vincenti